Development of In Vitro Susceptibility Testing Interpretive criteria for antibacterials

25/03/99

Click here to start

Table of Contents

Development of In Vitro Susceptibility Testing Interpretive criteria for antibacterials

Problems with application of Pharmacokinetics to ID

Problems with application of Pharmacokinetics to ID

Points to consider when integrating PK with MIC

Points to consider when integrating PK with MIC

Points to consider when integrating PK with MIC

Provisional Break Points: MIC

Provisional Break Points: MIC William A. Craig, 1995,Diagn Microbiol Infect Dis, 22:89-96

Provisional Break Points: MIC William A. Craig et al., Pk/Pd in OM, 1996,Pediatr Infect Dis J,15:255-9

Provisional Break Points: MIC

Provisional Break Points: MIC

Provisional Break Points: MIC

Provisional Break Points: MIC

Provisional Break Points: MIC

Provisional Break Points: MIC

Provisional Break Points: MIC Jerome J. Schentag et al.,1991, DICP Ann Pharmacother,25:1050-7

Provisional Break Points: Disk

Provisional Break Points: Disk

Final Break Points: Dilu. &Disk

Author: Sousan S. Altaie

Home Page: http://www.isap.org/past_activities.htm#ISAP/FDA workshop